HomeNRXP • NASDAQ
add
NRX Pharmaceuticals Inc
Previous close
$2.69
Day range
$2.42 - $2.66
Year range
$1.10 - $6.01
Market cap
45.30M USD
Avg Volume
264.82K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.75M | -37.53% |
Net income | -5.51M | 15.56% |
Net profit margin | — | — |
Earnings per share | -0.34 | 54.05% |
EBITDA | -3.75M | 37.54% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.55M | 320.62% |
Total assets | 7.59M | 100.37% |
Total liabilities | 32.75M | 73.68% |
Total equity | -25.16M | — |
Shares outstanding | 17.29M | — |
Price to book | -1.83 | — |
Return on assets | -166.67% | — |
Return on capital | 55.54% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.51M | 15.56% |
Cash from operations | -3.48M | 5.20% |
Cash from investing | — | — |
Cash from financing | 7.58M | 1,820.25% |
Net change in cash | 4.10M | 225.31% |
Free cash flow | 1.90M | 258.34% |
About
Founded
2015
Headquarters
Website
Employees
2
